Vaxcell-Bio Therapeutics Co., Ltd. develops and anticancer immunotherapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.
Frequently asked questions
What sector does Vaxcell-Bio Therapeutics Co. Ltd (323990) operate in?
Vaxcell-Bio Therapeutics Co. Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Vaxcell-Bio Therapeutics Co. Ltd (323990) current stock price?
As of the latest data, Vaxcell-Bio Therapeutics Co. Ltd stock price is ₩3,970, with a previous close of ₩3,970.
What is Vaxcell-Bio Therapeutics Co. Ltd (323990) current market capitalization?
Vaxcell-Bio Therapeutics Co. Ltd market cap is approximately 92.00 billion.
What is Vaxcell-Bio Therapeutics Co. Ltd (323990) EBITDA?
Vaxcell-Bio Therapeutics Co. Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.36 billion.
Does Vaxcell-Bio Therapeutics Co. Ltd (323990) pay dividends?
No. Vaxcell-Bio Therapeutics Co. Ltd does not pay a dividend.
What is Vaxcell-Bio Therapeutics Co. Ltd (323990) beta (volatility) score?
Vaxcell-Bio Therapeutics Co. Ltd has a beta of 3.721, indicating very high volatility compared to the market.